Recent Articles from Investor Brand Network

Efforts to legalize recreational cannabis through a constitutional amendment in Florida are facing a new hurdle: a recently passed state law that adds major roadblocks to the citizen initiative process. The group leading the marijuana amendment push, Smart & Safe Florida, has joined a federal lawsuit challenging the new law, arguing that it undermines Floridians’ fundamental right to propose and vote on constitutional changes.

Capstone Holding (NASDAQ: CAPS) reaffirmed its 2025 targets of a $100 million revenue run-rate and $10 million in adjusted EBITDA, supported by a strong M&A pipeline and disciplined cost control. The company is evaluating acquisition opportunities at 4–6x EBITDA multiples, with up to 45% non-cash consideration, and has secured an equity line of credit to support deals without upfront dilution. Subsidiary Instone remained on track despite seasonal headwinds, with cost run-rate guidance intact and growth expected to pick up in Q3.

As the global economy continues to evolve and diversify, investors are seeking opportunities in sectors with long-term growth potential and strong fundamentals. Precious metals, long viewed as stores of value and industrial cornerstones, are receiving renewed attention, particularly palladium. With its essential role in automotive, industrial and emerging technology applications, palladium is poised to remain a critical element in 2025 and beyond. Platinum Group Metals (NYSE American: PLG) (TSX: PTM), a development stage mining company, is strategically positioned to benefit from this momentum.

As artificial intelligence (“AI”) continues to revolutionize industries, the infrastructure supporting its growth — particularly data centers — has become increasingly reliant on copper due to its superior electrical conductivity. This surge in demand for copper presents significant opportunities for mining companies such as Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF), which is strategically positioned to supply this critical resource.

Brera Holdings (NASDAQ: BREA), a global sports investment group, announced the signing of a letter of intent to introduce the digital engagement platform PLAY LEAP to its portfolio of clubs, beginning with Italian Serie B side Juve Stabia. The initiative is part of a wider strategy to generate new digital revenue streams and broaden fan interaction and engagement.

Pre-production gold and silver resource developer ESGold (CSE: ESAU) (OTCQB: ESAUF) is announcing the appointment of seasoned mining executive and former global investment banker Peter Espig to its Board of Directors, establishing a vital leadership resource for the company as it prepares to transform itself from an exploration-stage junior into one of Canada’s important precious metals producers.

Bionoid Pharma (OTC PINK: BINP) has rebranded as AI Maverick Intel, Inc., signaling a strategic pivot toward artificial intelligence-powered customer acquisition and engagement solutions. The transformation follows the acquisition of AI Maverick Intel, a platform specializing in AI-based audience automation and intelligent two-way communication. The company aims to deploy its proprietary technology across healthcare, biotech, and other sectors to enhance targeting, engagement, and operational efficiency.

CNS Pharmaceuticals (NASDAQ: CNSP) reported a Q1 2025 net loss of $4.3 million, up from $3.5 million in the prior year period, as R&D spending increased to support data analysis for its Berubicin trial. The company remains focused on advancing TPI 287, a novel taxane with the potential to treat glioblastoma by crossing the blood-brain barrier. CNS has secured Orphan Drug Designation for TPI 287 and plans to initiate a Phase 2 study in recurrent GBM by late 2025. With $13.1 million in cash at quarter-end and an additional $5 million raised in May, the company expects to fund operations into the second half of 2026.

This week saw the prices of gold and silver futures drop as more reports showed that the U.S. and China’s trade war was easing. July silver prices dropped to $32.44 while June gold declined to $3222.50.

The recently unveiled Slate Truck could usher in a new age of electric mobility characterized by affordable and accessible electric pickup trucks. Approximately 47% of Americans own a pickup truck, with full-size models from the Ford F-Series, Chevrolet, and Ram being especially popular in the country. As automakers began pivoting to electric cars, some opted to develop electric trucks to tap into North America’s well-known demand for pickups.

Early diagnosis of lung cancer is pivotal to effective treatment because this disease is very challenging to treat. Advances in AI are transforming the screening for this disease, improving both efficiency and accuracy. Existing screening methods such as low-dose CT have several challenges. These include high rates of false-positives and a high variability when reporting other incidental but critical information, such as findings on cardiovascular diseases.

Artificial intelligence (AI) is often discussed through the lens of massive corporations, but that perspective overlooks the powerful influence small and medium-sized businesses (SMBs) have on the global economy.

FingerMotion (NASDAQ: FNGR), has entered the Indonesian market via its subsidiary, Finger Motion Financial Company Limited, by signing an agreement with PT Mach Wireless Teknologi to deploy its AI-driven insurance risk rating platform. Tailored for local underwriting in motor, health, and life insurance, the platform will integrate with Indonesia’s telco-insurance ecosystem. The company is in final talks with a major Indonesian telecom provider to support the rollout. This marks a key milestone in FingerMotion’s Southeast Asia expansion strategy, blending AI, big data, and regional partnerships to transform digital insurance delivery.

NanoViricides, Inc. (NYSE American: NNVC) filed its Q1 2025 report and announced progress on NV-387, its broad-spectrum antiviral drug candidate. The company has received clearance from the DRC’s National Ethics Committee to submit a Phase II trial application for MPox and is also initiating programs targeting measles and avian flu. NV-387 previously completed Phase I with no adverse events and has shown superior activity in animal models compared to approved antivirals for COVID, influenza, RSV, and smallpox. Financially, NNVC reported $2.73 million in cash, $6.98 million in property and equipment, and $1.2 million in current liabilities, but indicated that additional funding is needed to support operations beyond early 2026.

Silo Pharma (NASDAQ: SILO) has priced a public offering of approximately 3.33 million shares of common stock (or pre-funded warrants) along with Series A-1 and Series A-2 warrants, all priced at $0.60 per unit. The Series A-1 and A-2 warrants are immediately exercisable at $0.60 per share, with expirations set at five years and eighteen months, respectively. Gross proceeds are expected to total roughly $2 million before fees and expenses. H.C. Wainwright & Co. is acting as the exclusive placement agent, and proceeds will support general working capital.

French authorities are currently investigating a disturbing trend involving the abduction of individuals tied to the crypto world. The latest case involves a 60-year-old man whose finger was severed by kidnappers demanding that his son, a crypto-millionaire, pay ransom for his release. The victim, who runs a crypto marketing firm alongside his son, was held captive for over two days before being rescued by police.

German authorities have confiscated around $38 million worth of cryptocurrency from an exchange known as eXch, a platform suspected of helping cybercriminals launder stolen funds. This includes money linked to the $1.4 billion Bybit hack that happened earlier this year.

The entire Iberian Peninsula recently experienced a massive blackout that left most of mainland Spain, Portugal, and parts of southern France without electrical power for around 10 hours. Some opposition parties in Spain, as well as a few external observers, have pointed to net-zero emission goals and renewable energy targets as potential contributors to the outage .

SolarBank (NASDAQ: SUUN) (CSE: SUNN) President and CEO Dr. Richard Lu appeared on the GotStocks Podcast to discuss the company’s vertically integrated model and its $184 million portfolio of revenue-generating clean energy assets. Lu detailed how SolarBank develops, builds, owns, and operates distributed and community solar projects across Canada and the U.S., including partnerships with Honeywell and Qcells. He also highlighted a recent $100 million financing agreement with CIM Group to fund 97 MW of U.S. projects, positioning the company for continued long-term growth.

NRx Pharmaceuticals (NASDAQ: NRXP) reported a Q1 2025 net loss of $5.5 million, down from $6.5 million in the same period last year, with operating losses narrowing to $3.8 million. The company advanced regulatory and commercial milestones for its two lead programs: NRX-100, a preservative-free IV ketamine formulation for suicidal depression now supported by an NDA fee waiver and new patent filing; and NRX-101, an oral treatment for bipolar depression with a PDUFA date anticipated before year-end. Subsidiary HOPE Therapeutics also gained momentum with $10.3 million in new acquisition funding to support a national psychiatry clinic rollup. NRx ended the quarter with $5.5 million in cash and expects its current capital and financing plans to support operations through year-end.

The marijuana sector is facing a growing financial crisis that’s been developing quietly while many businesses ignore the signs. The core issue? An explosion in unpaid invoices that’s threatening to destabilize the entire supply chain. Despite some whispers in online forums and informal industry circles, there has been little serious discussion about the scale of the problem or the risks it poses.

Adageis, a forward-thinking healthcare technology company, is empowering clinics and medical groups to succeed in the shift from fee-for-service to value-based care through its AI-powered platform. The company’s ProActive Care solution deciphers complex insurance contracts, integrates with leading EHR systems, and offers real-time analytics to help providers track revenue trends as well as their performance and profitability. Proprietary components of the platform, including the Value-Based Care Engine and Patented Risk Engine, identify care gaps and high-risk patients, enabling earlier interventions that enhance both clinical and financial performance. By developing targeted solutions, with a focus on smaller and independent practices, Adageis aims to make value-based care more accessible and profitable while driving data-driven operational decisions.

Nutriband (NASDAQ: NTRB), a company focused on the development of a portfolio of transdermal pharmaceutical products, is expanding its market presence and manufacturing capabilities through two new strategic partnerships. The company is collaborating with Charlotte FC to build brand visibility, particularly for its AI Tape and AVERSA(TM)—Nutriband’s proprietary technology that it believes has the potential to be the world’s first and only abuse deterrent patch platform for managing chronic pain. The company also deepened its collaboration with Kindeva Drug Delivery through an amended agreement focused on the development of Aversa(TM) Fentanyl, which combines Nutriband’s abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch. Through existing and new alliances with established brands in the health and wellness industry, Nutriband aims to diversify its revenue streams and reinforce its position as a leader in transdermal drug delivery solutions.

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted this week in a Zacks Small-Cap Research report that presented a favorable analysis, noting that the company’s Phase 3 cutaneous T-cell lymphoma (“CTCL”) study is continuing and that the trial has a high probability of success.

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a term sheet with Universal Capital, LLC for $7.8 million in acquisition funding to support the rollout of its national interventional psychiatry clinic network. Combined with previously announced investments, HOPE now has $10.3 million in capital to execute initial acquisitions of Dura Medical, Kadima, and NeuroSpa. These clinics offer neuroplastic treatments such as ketamine and transcranial magnetic stimulation to treat severe depression and PTSD, with current contracts in place to serve veterans through the VA. Universal Capital expects to participate in future funding rounds as HOPE expands its platform nationwide.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, reported a significant increase in revenue, gross profit, and cash reserves for the first quarter of fiscal 2025, enabled by the sale of a high-margin annealing quantum computing system. The results, detailed in a conference call hosted by CEO Dr. Alan Baratz and CFO John Markovich on May 8, signal the company’s continuing momentum in driving commercial adoption of quantum computing ( https://ibn.fm/UoZWf ).

The powersports and recreational watercraft industries are experiencing a notable upswing, driven by consumers’ growing appetite for outdoor adventures and leisure activities. Amid this surge, Massimo (NASDAQ: MAMO), a Texas-based manufacturer and distributor, is emerging as a significant player, capitalizing on market trends and expanding its footprint in the sector.

Intelligent Bio Solutions (NASDAQ: INBS) reported continued commercial growth, surpassing 450 active accounts with 35 added in fiscal Q3, driven by demand for its rapid, non-invasive fingerprint drug testing system. The company expanded into new sectors including luxury marine, retail, and waste management, while entering remote regions across Europe and Australia. INBS now operates in 24 countries and partners with 18 distributors across 19 nations. These milestones support the company’s global expansion strategy and position it for entry into the multi-billion-dollar U.S. testing market.

Telomir Pharmaceuticals (NASDAQ: TELO) announced the identification of Telomir-Ag2, a stabilized Silver(II) complex demonstrating potent, broad-spectrum antimicrobial activity, including against drug-resistant MARSA. Developed using the company’s proprietary Telomir-1 platform, Telomir-Ag2 is the first Silver(II) compound to achieve biological compatibility, outperforming its Silver(I) predecessor in preclinical studies. Designed for use in high-risk infections such as burns and surgical wounds, the drug candidate targets the growing $1.36 billion silver wound care market and $33.7 billion antimicrobial coatings market. Telomir plans to advance Telomir-Ag2 into IND-enabling studies and explore strategic partnerships.

Datavault AI (NASDAQ: DVLT) filed Q1 2025 results and reaffirmed its 2026 revenue target of $40 million to $50 million, projecting $12 million to $15 million in revenue in the second half of 2025. The company expects to close its acquisition of CompuSystems Inc. during the week of May 19. Recent strategic milestones include joining IBM’s Partner Plus, licensing its ADIO(R) ultrasonic advertising tech to NYIAX, and launching a secure tokenized data vending platform with Kove IO. Datavault also advanced its VerifyU strategy through a deal with the NFL Alumni Association.

Battery swapping is becoming a popular alternative to conventional charging in several markets. As the name suggests, this process involves exchanging a depleted EV battery with a fully charged one, eliminating the long wait times associated with traditional electric vehicle charging. As an alternative to plug-in charging, battery swapping offers a user experience that can be just as fast as refueling a gasoline-powered car.

The energy storage sector is undergoing a transformative shift, with lithium iron phosphate (LFP) batteries taking center stage. Experts speaking ahead of the upcoming NetZero Milan Expo-Summit 2025 emphasize that LFP’s growing dominance has been driven by advantages such as enhanced safety, longer lifespan, reduced costs, and consistent performance.

While President Trump signed an order aimed at reducing the high cost of prescription drugs in the U.S., it isn’t clear how exactly the price reduction will be achieved and how such reductions could impact the country in the long term.

The growing interest in artificial intelligence (AI) is raising concerns about misinformation and premature decision-making. A notable example involved a fabricated quote attributed to Apple CEO Tim Cook. When asked to provide statements from tech leaders on the relevance of AI in modern business, OpenAI’s ChatGPT generated a quote that claimed AI was boosting efficiency and growth. However, upon further inquiry, the chatbot revealed that no such comment had been officially made by Cook in any verified speech or communication.

Calidi Biotherapeutics (NYSE American: CLDI) reported a Q1 2025 net loss of $5.0 million, narrowing from $7.2 million in the prior year, with R&D and G&A expenses also declining. The company highlighted FDA clearance of its IND for CLD-201, an allogeneic stem cell-based immunotherapy for solid tumors, and presented promising Redtail platform data at AACR showcasing IL15 superagonist delivery via engineered oncolytic virus. Calidi also announced key leadership additions, including CEO Dr. Eric Poma and CMO Dr. Guy Clifton, as it advances systemic virotherapies targeting metastatic cancers.

Brera Holdings (NASDAQ: BREA) welcomed reports that Eagle Football Holdings, a $2 billion multi-club ownership group, is preparing to file for an IPO. Eagle’s portfolio includes stakes in Crystal Palace, Lyon, Botafogo, and Molenbeek. Brera Executive Chairman Dan McClory expressed support for the move, citing its potential to raise investor awareness of the MCO model and sports as an asset class. Brera, which completed its own Nasdaq listing in 2023, said it continues aligning with the sustainable football investment approach recently highlighted in The Wall Street Journal.

Vivakor (NASDAQ: VIVK) is a vertically integrated energy infrastructure and environmental services company, focused on the transportation, storage, reuse, and remediation of oilfield fluids and waste. The company operates a large-scale oilfield trucking fleet, serving key U.S. energy regions, enabling end-to-end solutions for the handling of crude oil and produced water. Through long-term contracts and strategic asset positioning, Vivakor delivers critical services to upstream energy operators seeking efficient and environmentally responsible operations.

Cybin (NYSE American: CYBN) (NEO: CYBN) has partnered with Thermo Fisher Scientific to support Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin treatment for major depressive disorder (MDD). The agreement expands on Cybin’s existing U.S.-based manufacturing operations, with Thermo Fisher handling drug substance in South Carolina and capsule production in Ohio. CYB003 received FDA Breakthrough Therapy Designation in March 2024, and its ongoing Phase 3 PARADIGM trial follows strong Phase 2 results showing a 100% response rate and 71% remission with two 16 mg doses.

SKYX Platforms (NASDAQ: SKYX) reported record Q1 2025 revenue of $20.1 million, up 6% year-over-year, driven by growth in its smart and standard plug & play product sales. The company’s gross profit rose to $5.7 million while net loss per share narrowed to ($0.09). SKYX raised $4 million in new equity as part of a $15 million financing round led by The Shaner Group and company insiders. Strategic collaborations with Home Depot, Wayfair, Cavco Homes, and multiple luxury developments are expanding market penetration. Management reaffirmed expectations for positive cash flow in 2025 as its products reach 30,000 homes by the end of Q2 and continue scaling across the U.S. and Canada.

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) has initiated a series of investor awareness and marketing agreements aimed at expanding its visibility. The Company engaged InvestorBrandNetwork for a yearlong communications campaign starting May 8, 2025, at $23,200 per quarter, and Goldinvest Consulting for six months beginning May 5 to support outreach in Germany at EUR 4,050 per month. Ucore also signed a 12-month media agreement with Outside the Box Capital, which includes $160,000 in cash, 100,000 stock options, and a $25,000 influencer campaign budget, pending TSXV approval.

Newton Golf Company (NASDAQ: NWTG) reported a 246% year-over-year revenue increase to $1.2 million in Q1 2025, driven by surging demand for its Newton Motion and Fast Motion shafts. Gross profit rose to $852,000 with margin expansion to 70%, while net loss narrowed to $0.5 million. More than 30 professionals have adopted Newton shafts, including 8 new players across major tours in Q1. The company also expanded into Japan, added key international distribution, and expects full-year revenue between $6.5 million and $7.0 million.

Silo Pharma (NASDAQ: SILO) has partnered with Veloxity Labs to conduct GLP-compliant bioanalysis for its ongoing toxicology and toxicokinetics study of SPC-15, an intranasal treatment aimed at preventing PTSD. The data will support an FDA investigational new drug submission expected in 2025. If approved, Silo plans to advance SPC-15 into a Phase 1 human clinical trial.

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) reported Q1 2025 gold production of 35,578 ounces at an all-in sustaining cost of $960/oz, generating $24.4 million in net income and $36.0 million in free cash flow. With $149 million in cash and no lost time or recordable incidents, the company remains on track to meet 2025 guidance. GMIN advanced early works at Oko West and released a feasibility study outlining a $2.2 billion NPV at $2,500 gold. Proven and probable reserves rose to 6.7 million ounces, and the company gained inclusion in three major mining indices, boosting institutional visibility.

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) will release its financial results for the quarter ended March 31, 2025, after market close today, May 15, and will host a webinar at 4:30 p.m. ET to provide a business update and discuss the quarterly performance.

Sustain Southern California is proud to announce this year’s Agriculture, Food Systems & Waste Stream Innovations event, promising an agenda packed with solutions in circularity. Scheduled for May 15 from 1:00 p.m. to 7:00 p.m., this event brings together key stakeholders in agriculture to discuss agtech, urban agriculture, composting needs, policy issues, and more.

The Trump administration is considering eliminating various Biden-era climate action policies designed to invest in America’s burgeoning green energy industry. U.S. House representatives recently introduced plans to phase out renewable energy tax credits, cut federal spending on clean energy and electric vehicles, and pull back funding dedicated to climate action in an attempt to pass a budget that aligns with President Donald Trump’s anti-green energy agenda .

U.S. President Donald Trump’s latest venture into the crypto world is stirring up controversy, criticism, and speculation. On Monday, the top two hundred and twenty investors in a Trump-branded digital token secured an invitation to a private dinner with the president . The dinner, scheduled for May 22 in Washington, D.C., is being presented as a reward for those who spent the most on the crypto known as $TRUMP.

In the global race to develop better, faster, and more efficient batteries, China is quickly emerging as a clear leader. While many countries are still exploring new possibilities, China has already taken major steps in transforming battery technology, with real-world results to show for it.

NextPlat (NASDAQ: NXPL, NXPLW) reported Q1 2025 revenue of $14.5 million, down from $17.5 million in the prior year, driven by changes in 340B pharmacy agreements and prescription volume. Gross margin declined to 23.8%, while operating expenses fell 26% to $4.9 million due to reduced legal and non-recurring costs. Net loss narrowed to $1.3 million, or ($0.05) per share. The company ended the quarter with $17.7 million in cash and expanded its e-Commerce reach, including a 51% increase in recurring airtime revenue and growing OPKO product sales in China. Management remains focused on high-margin services and strategic healthcare growth.

New York Governor Kathy Hochul signed the state’s latest budget into law on Friday, but one key proposal that had stirred significant backlash didn’t make it into the final version. Earlier this year, Hochul had proposed allowing police to use the smell of cannabis as a reason to suspect a driver of being under the influence and require them to undergo a drug test.

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), through its joint venture with American West Metals, has secured a strategic partnership with Ocean Partners Holdings to significantly advance the Storm Copper Project in Nunavut, Canada. The deal includes up to 80% project development financing and a binding offtake agreement granting Ocean Partners exclusive rights to copper and silver products from near-surface mineralization. Backed by a US$3.5 million second tranche payment from Taurus Mining Royalty and C$0.996 million to Aston Bay, the funding will support aggressive exploration and pre-feasibility efforts in 2025.

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is scheduled to report its first quarter 2025 financial results after the market closes on Thursday, May 15. A conference call and webcast will follow at 4:30 p.m. ET, accessible via the company’s investor relations site or by dialing +1-800-717-1738 (U.S.) or +1-646-307-1865 (international).

Cannabis Means Business (“CMB”) today announced that Whoopi Goldberg will participate in a fireside chat and launch her new hemp-derived beverage, Whoop-Tea, at CMB 2025 , taking place on June 4–5 at the Javits Center in New York City . The Emmy, Grammy, Oscar, and Tony Award-winning entertainer and entrepreneur will join CNBC’s Tim Seymour on Wednesday, June 4 , for an exclusive conversation in the Special Events Area on the CMB exhibit floor. The discussion will delve into the fast-rising cannabis beverage market and the vision behind Whoop-Tea , created in collaboration with leading cannabis beverage brand Pure Genesis .

Sustain Southern California (“Sustain SoCal”) has announced its upcoming event, Agriculture, Food Systems and Waste Stream Innovations, slated to take place in Irvine, California, on Thursday, May 15, 2025. The synergistic agenda will drive comprehensive discussions along the entire spectrum of the supply chain, from agtech, farm-to-table, packaging innovations, and waste management policy.

SurgePays (Nasdaq: SURG) has entered into a $7 million senior secured convertible note agreement with a current institutional shareholder, providing $6 million in cash and involving a repurchase of 333,333 shares. The two-year note is convertible into common stock at $4.00 per share, a premium to current market price, and includes a prepayment option at a 2% premium. Proceeds will support the national launch of LinkUp Mobile and the growth of SurgePays’ MVNE wholesale platform following its April 1 integration with AT&T. Management projects over $200 million in revenue and positive cash flow from operations by year-end 2025.

NanoViricides, Inc. (NYSE American: NNVC) provided a strategic update on its antiviral pipeline, highlighting NV-387 as a potential breakthrough treatment for Measles and MPox amid rising global case counts and vaccine failures. The company has begun preparations for animal efficacy studies for Measles and will make NV-387 available under FDA’s Individual Patient Expanded Access. In the DRC, its Phase II Clinical Trial Application for MPox has been cleared by the national ethics committee. NV-387 is also being developed for broad respiratory infections in a basket trial format and for pan-herpesvirus treatment. With no current approved drugs for Measles or MPox, NanoViricides aims to fill critical gaps in global antiviral preparedness.

When most people think about electric cars, China isn’t the first name that comes to mind, but maybe it should be. Toyota has just sounded the alarm, and it’s not just about electric vehicles anymore. According to the company, China’s rise in the auto world is happening fast and across more than one area.

A viral video on social media platform TikTok is popularizing a quick and easy hand test that can reportedly reveal if someone has an undiagnosed brain tumor . The British medic who demonstrated the 30-second test on the TikTok account claims that it can help individuals identify serious brain health issues that haven’t been diagnosed yet.

Silo Pharma (NASDAQ: SILO) has partnered with Frontage Laboratories to conduct a 7-day safety and toxicology study of its lead asset, SPC-15, following a request from the FDA. The intranasal treatment targets PTSD and stress-related disorders, and the study is expected to strengthen Silo’s upcoming IND application. Silo remains on track for an FDA submission this year and is concurrently running a GLP-compliant toxicology study. SPC-15, developed in collaboration with Columbia University, is a 5-HT4 receptor agonist potentially eligible for the FDA’s 505(b)(2) pathway.

Knightscope (NASDAQ: KSCP) reported Q1 2025 revenue of $2.9 million, up 29% year-over-year, while net loss narrowed to $6.9 million, a 19% improvement. The company improved gross margin loss to (23%) from (64%) and cut G&A expenses by 24%. Knightscope ended the quarter with $12.7 million in cash and a $2.5 million backlog. Strategic initiatives included securing a 33,000-square-foot headquarters in Sunnyvale, California, and raising $8.8 million in equity offerings. The company will present at the Ladenburg Thalmann Innovation EXPO25 on May 21 in New York.

Massimo (NASDAQ: MAMO) is entering a new growth phase with the launch of a comprehensive digital retail platform. This move, announced in April 2025, is designed to simplify the purchasing process for its UTVs, ATVs, and mini-bikes, while expanding the company’s national sales footprint.

ESGold (CSE: ESAU) (OTCQB: ESAUF) President Brad Kitchen appeared on the latest episode of The MiningNewsWire Podcast to discuss the company’s fully permitted Montauban project and near-term path to gold and silver production. Kitchen emphasized ESGold’s unique model of funding exploration through early-stage tailings production, citing an estimated $100 million in recoverable material from the historic mine. He also highlighted the project’s community impact, operational goals for 2025, and a tightly aligned marketing plan to increase visibility as production ramps.

Tonix Pharmaceuticals (NASDAQ: TNXP) has appointed Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations. Hand brings decades of leadership experience across legal, HR, and corporate services, including a pivotal role in Celgene’s $74 billion acquisition by Bristol Myers Squibb and the $13.4 billion divestiture of Otezla® to Amgen. His addition comes as Tonix prepares for a potential launch of TNX-102 SL for fibromyalgia, pending FDA approval.

HeartBeam (NASDAQ: BEAT) reported Q1 2025 results highlighted by successful completion of the VALID-ECG pivotal study, supporting its 510(k) submission for 12-lead ECG synthesis software and confirming productive ongoing FDA discussions. The company launched an Early Access Program, signed a strategic partnership with AccurKardia to integrate its FDA-cleared AccurECG(TM) software, added two new U.S. patents to bring its IP total to 20, appointed CEO Robert Eno to its board, and raised $11.5 million through a public offering to support commercialization plans.

FAVO Capital (OTC: FAVO), a provider of revenue-based funding solutions for SMBs, announced its participation in the D. Boral Capital Inaugural Global Conference on May 14, 2025, at The Plaza Hotel in New York City. President Shaun Quin will represent the company in meetings with institutional investors, highlighting FAVO’s growth strategy and IPO readiness. CEO Vincent Napolitano emphasized the event as a key platform to expand visibility and engage potential investors ahead of the company’s planned uplisting.

Cybin (NYSE American: CYBN) (NEO: CYBN) announced that CEO Doug Drysdale will participate in a fireside chat at the virtual Alliance Global Partners Healthcare Company Showcase on May 21, 2025. The session will be webcast live at 1:40 p.m. ET and later available via the company’s investor relations site.

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on brain and central nervous system cancers, has priced a “reasonable best efforts” public offering with a single healthcare-focused institutional investor, raising approximately $5 million in gross proceeds. The offering includes 3,952,570 shares of common stock at $1.265 per share and accompanying Series F warrants to purchase an equal number of shares at $1.14 per share, exercisable immediately and valid for five years. A.G.P./Alliance Global Partners is acting as the sole placement agent. Proceeds will be used for working capital and general corporate purposes. Closing is expected on or about May 14, 2025.

Annovis Bio (NYSE: ANVS) initiated its pivotal Phase 3 clinical trial in early Alzheimer’s disease during Q1 2025, with enrollment now underway for up to 760 participants to assess buntanetap’s symptomatic and disease-modifying effects over 18 months. The company also secured a new U.S. patent for buntanetap and participated in several key scientific and investor conferences, including Oppenheimer’s 35th Annual Healthcare Life Sciences Conference and AD/PD(TM) 2025 in Vienna. Cash and equivalents rose to $22.2 million as of March 31, 2025, while R&D expenses fell year-over-year to $5.0 million.

SOBRsafe (NASDAQ: SOBR) has appointed Kris Pederson, a veteran corporate director with leadership roles at EY, IBM (NYSE: IBM), and PwC, to its Board of Directors effective May 1, 2025, where she will also chair the Nominating and Corporate Governance Committee. The Company also named Dr. Benjamin Sanchez as a Scientific Advisor in February to support federal funding and clinical research partnerships. The additions bring deep expertise in governance, digital innovation, and biomedical engineering as SOBRsafe continues scaling its alcohol detection technology platform.

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) is nearing the commissioning of its RapidSX(TM) Commercial Demonstration Plant in Kingston, Ontario, a key milestone in its plan to commercialize its advanced rare earth element (REE) separation technology. The company is also preparing to construct its first Strategic Metals Complex (SMC) in Louisiana, expected to process 2,000 tons of total rare earth oxides by the end of 2024 and scale to 5,000 tons in 2026. Ucore’s long-term roadmap includes additional SMCs in Alaska and Canada, alongside the development of its 100%-owned Bokan-Dotson Ridge HREE resource in Alaska. With strong U.S. and Canadian government support and partnerships with Kingston Process Metallurgy and Mech-Chem Associates, Ucore aims to establish a complete North American REE supply chain independent of China.

Artificial intelligence (“AI”) is rapidly transforming the marketing landscape, enabling businesses to deliver more personalized, efficient and data-driven campaigns. As companies seek to harness the power of AI to stay competitive, ONAR Holding Corp. (OTCQB: ONAR) is at the forefront with its innovative Cortex platform, poised to redefine the future of advertising.

The nickel mining industry in Indonesia has reacted negatively to the government’s increase of mining royalties from 10% to rates that vary from 14-19%. The change took effect at the start of May. The government is looking at these increased royalties as a source of needed revenue to fund the ambitious programs initiated by President Subianto. For example, he started a program to offer free meals for pregnant mothers and children. He has also established a sovereign wealth fund for the country.

SKYX Platforms (NASDAQ: SKYX), a smart home platform technology company with over 97 issued and pending patents, announced it has raised approximately $4 million from strategic investors through preferred stock priced at $2.00 per share. The investment is part of a broader $15 million financing round led by The Shaner Group, with additional participation from SKYX insiders including President Steve Schmidt and Co-CEOs Lenny Sokolow and John Campi. The funding will support general working capital and corporate initiatives as the company advances its home innovation platform and e-commerce portfolio.

President Donald Trump has announced that he’s pulling his nomination for Ed Martin, who was set to become the U.S. attorney for Washington, D.C.

MoneyShow, a leading producer of live and online financial conferences for investors, traders, and financial advisors, today announced the upcoming “ Navigating Volatility, Finding Opportunity: A Virtual Expo ,” set to take place May 21-22, 2025. “Investors face several key issues in this market environment. They include far-reaching U.S. tariffs, geopolitical tensions, inflation concerns, evolving trade dynamics, the potential for interest rate cuts, and the surge in safe-haven assets,” said MoneyShow’s Editor-in-Chief Mike Larson. “Our star-studded line-up of speakers will provide attendees with in-depth context to the latest market moves. They will also share highly actionable insights on minimizing risks in choppy seas, maximizing profit avenues, and repositioning portfolios to manage uncertainty across the second half of the year.”